OWA
ABBV icon

Opal Wealth Advisors’s AbbVie ABBV Stock Holding History

Opal Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Buy
6,171
+1,619
+36% +$348K 0.34% 34
2026
Q1 		$990K Sell
4,552
-85
-2% -$18.9K 0.22% 44
2025
Q4 		$1.06M Buy
4,637
+28
+0.6% +$6.38K 0.28% 44
2025
Q3 		$1.07M Sell
4,609
-341
-7% -$69.4K 0.3% 40
2025
Q2 		$919K Sell
4,950
-371
-7% -$69K 0.25% 45
2025
Q1 		$1.11M Buy
5,321
+86
+2% +$16.7K 0.34% 34
2024
Q4 		$930K Buy
5,235
+53
+1% +$9.74K 0.28% 50
2024
Q3 		$1.02M Buy
5,182
+11
+0.2% +$2.05K 0.32% 44
2024
Q2 		$887K Buy
5,171
+110
+2% +$18.2K 0.28% 44
2024
Q1 		$922K Sell
5,061
-760
-13% -$131K 0.31% 43
2023
Q4 		$902K Sell
5,821
-967
-14% -$141K 0.36% 44
2023
Q3 		$1.01M Buy
6,788
+78
+1% +$11.5K 0.59% 27
2023
Q2 		$904K Buy
6,710
+609
+10% +$89.3K 0.45% 28
2023
Q1 		$972K Buy
6,101
+747
+14% +$114K 0.57% 20
2022
Q4 		$865K Buy
5,354
+115
+2% +$17.6K 0.48% 31
2022
Q3 		$703K Buy
5,239
+322
+7% +$46.2K 0.51% 28
2022
Q2 		$753K Buy
4,917
+69
+1% +$10.5K 0.5% 29
2022
Q1 		$786K Buy
4,848
+27
+0.6% +$3.92K 0.68% 23
2021
Q4 		$653K Buy
4,821
+191
+4% +$22.6K 0.41% 41
2021
Q3 		$499K Sell
4,630
-164
-3% -$18.7K 0.48% 29
2021
Q2 		$540K Buy
4,794
+247
+5% +$27.8K 0.5% 30
2021
Q1 		$492K Buy
4,547
+168
+4% +$18K 0.53% 28
2020
Q4 		$469K Buy
+4,379
New +$421K 0.59% 25

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Opal Wealth Advisors's ABBV Position: Q2 2026 in Review

Opal Wealth Advisors increased its AbbVie (ABBV) stake by 36% in Q2 2026, buying an estimated $348K and bringing the position to 6,171 shares worth $1.55M. The position accounts for 0.34% of the portfolio, ranked #34.

Opal Wealth Advisors first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Opal Wealth Advisors held 6,171 shares of AbbVie worth $1.55M as of Q2 2026.
  • Opal Wealth Advisors bought 1,619 AbbVie shares in Q2 2026, an estimated $348K.
  • AbbVie made up 0.34% of Opal Wealth Advisors's portfolio in Q2 2026, its #34 holding.
  • Opal Wealth Advisors first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Opal Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.